Thermo Fisher Scientific Inc (TMO)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 4,009,000 | 4,645,000 | 7,084,000 | 5,506,000 | 8,077,000 | 6,151,000 | 3,133,000 | 3,482,000 | 8,524,000 | 2,919,000 | 1,888,000 | 2,752,000 | 4,477,000 | 12,027,000 | 7,023,000 | 5,583,000 | 10,325,000 | 7,540,000 | 5,818,000 | 2,981,000 |
| Short-term investments | US$ in thousands | 1,561,000 | 2,000,000 | 1,750,000 | 1,751,000 | 3,000 | — | — | — | 2,000 | 22,000 | 5,000 | 150,000 | — | — | 65,000 | 121,000 | 28,000 | 697,000 | — | 110,000 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 13,332,000 | 14,601,000 | 14,772,000 | 13,937,000 | 14,012,000 | 14,158,000 | 14,112,000 | 15,884,000 | 17,010,000 | 11,118,000 | 10,997,000 | 12,070,000 | 13,436,000 | 7,753,000 | 6,925,000 | 6,995,000 | 10,304,000 | 6,228,000 | 6,013,000 | 5,500,000 |
| Quick ratio | 0.42 | 0.46 | 0.60 | 0.52 | 0.58 | 0.43 | 0.22 | 0.22 | 0.50 | 0.26 | 0.17 | 0.24 | 0.33 | 1.55 | 1.02 | 0.82 | 1.00 | 1.32 | 0.97 | 0.56 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($4,009,000K
+ $1,561,000K
+ $—K)
÷ $13,332,000K
= 0.42
Thermo Fisher Scientific Inc's quick ratio has fluctuated over the analyzed periods. The quick ratio started at a relatively low level of 0.56 on March 31, 2020, indicating a weaker ability to meet short-term obligations with liquid assets. However, there was a steady improvement in the quick ratio over the next several quarters, reaching a peak of 1.55 on September 30, 2021, suggesting a stronger liquidity position during that period.
Subsequently, the quick ratio experienced a decline, dropping to 0.17 on June 30, 2022, which could signal potential challenges in meeting short-term obligations with readily available assets. The quick ratio continued to fluctuate, showing mixed performance in maintaining liquidity adequacy.
Overall, the quick ratio of Thermo Fisher Scientific Inc exhibited variability, with periods of both strength and weakness in liquidity management. Investors and stakeholders should closely monitor the trend of the quick ratio to assess the company's ability to cover short-term liabilities with current assets efficiently.
Peer comparison
Dec 31, 2024